Filing Details
- Accession Number:
- 0001213900-15-009520
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-12-16 16:25:45
- Reporting Period:
- 2015-12-14
- Filing Date:
- 2015-12-16
- Accepted Time:
- 2015-12-16 16:25:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1553643 | Relmada Therapeutics Inc. | RLMD | Pharmaceutical Preparations (2834) | 455401931 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1565832 | Sergio Traversa | C/O Relmada Therapeutics, Inc. 757 Third Avenue, Suite 2018 New York NY 10017 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-12-14 | 30 | $2.97 | 320,352 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
